XRF Scientific Income Statement

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Revenue	62.05	59.45	60.12	55.26	40.01	31.29
Revenue Growth (YoY)	3.08%	-1.11%	8.79%	38.12%	27.84%	7.57%
Cost of Revenue	31.7	30.65	33.57	32.28	22.69	17.5
Gross Profit	30.34	28.79	26.55	22.98	17.32	13.79
Selling, General & Admin	13.67	12.93	11.81	10.14	8.53	7.41
Other Operating Expenses	1.35	1.05	1	0.88	0.56	0.42
Operating Expenses	15.03	13.98	12.81	11.01	9.09	7.83
Operating Income	15.32	14.82	13.74	11.97	8.23	5.96
Interest Expense	-0.2	-0.26	-0.29	-0.22	-0.07	-0.03
Other Non Operating Income (Expenses)	0.03	0.03	0.01	0.04	0.03	0
EBT Excluding Unusual Items	15.15	14.59	13.46	11.79	8.19	5.93
Other Unusual Items	-	-	-	-	-	0.86
Pretax Income	15.15	14.59	13.46	11.79	8.19	6.79
Income Tax Expense	4.52	4.25	3.97	3.61	2.1	1.66
Earnings From Continuing Operations	10.63	10.34	9.5	8.18	6.09	5.13
Minority Interest in Earnings	-	0.05	-0.61	-0.5	-0.01	-
Net Income	10.63	10.38	8.89	7.69	6.08	5.13
Net Income to Common	10.63	10.38	8.89	7.69	6.08	5.13
Net Income Growth	12.93%	16.86%	15.61%	26.33%	18.58%	64.37%
Shares Outstanding (Basic)	142	140	138	137	135	134
Shares Outstanding (Diluted)	142	140	138	137	135	134
Shares Change (YoY)	2.16%	1.72%	0.80%	0.90%	0.84%	0.39%
EPS (Basic)	0.08	0.07	0.06	0.06	0.04	0.04
EPS (Diluted)	0.07	0.07	0.06	0.06	0.04	0.04
EPS Growth	11.87%	15.63%	14.28%	24.70%	18.18%	65.22%
Free Cash Flow	10.17	8.39	6.48	7.66	2.78	4.1
Free Cash Flow Per Share	0.07	0.06	0.05	0.06	0.02	0.03
Dividend Per Share	0.045	0.045	0.039	0.033	0.025	0.020
Dividend Growth	15.38%	15.38%	18.18%	32.00%	25.00%	42.86%
Gross Margin	48.91%	48.44%	44.16%	41.59%	43.30%	44.07%
Operating Margin	24.69%	24.92%	22.86%	21.66%	20.58%	19.05%
Profit Margin	17.14%	17.47%	14.78%	13.91%	15.21%	16.39%
Free Cash Flow Margin	16.39%	14.12%	10.78%	13.86%	6.95%	13.10%
EBITDA	15.71	15.63	14.46	12.57	8.83	6.58
EBITDA Margin	25.31%	26.29%	24.06%	22.75%	22.07%	21.01%
D&A For EBITDA	0.39	0.81	0.72	0.6	0.6	0.62
EBIT	15.32	14.82	13.74	11.97	8.23	5.96
EBIT Margin	24.69%	24.92%	22.86%	21.66%	20.58%	19.05%
Effective Tax Rate	29.83%	29.15%	29.46%	30.61%	25.62%	24.42%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.